1. Featured Article: Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells
   Ou Huang et al, 2015, Experimental Biology and Medicine CrossRef
2. Anti-inflammatory drug, leflunomide and its metabolite teriflunomide inhibit NSCLC proliferation in vivo and in vitro
   Liyang Jiang et al, 2018, Toxicology Letters CrossRef
3. Leflunomide: A promising drug with good antitumor potential
   Chunying Zhang et al, 2018, Biochemical and Biophysical Research Communications CrossRef
4. Teriflunomide Loaded SPION Nanoparticles Induced Apoptosis in MDA-MB-231 Breast Cancer Cells
   Tina Rabizadeh et al, 2023, Journal of Cluster Science CrossRef
5. Dexamethasone–tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells
   Aliaa I. Gaballah et al, 2024, Bioscience Reports CrossRef